Quarterly insight from our fixed income teams to help clients navigate the markets and opportunities ahead.
Research analysts Josh Cummings, Tom DeLong and Joe Furmanski discuss the disruption of traditional video distributors driven by the increase in Internet-delivered streaming.
Disruption is rippling through the global economy, and the pace of change is accelerating. Change and innovation are always present, but read more to learn why today is different.
Global Life Sciences Co-Portfolio Manager Ethan Lovell discusses how faster, more accurate diagnoses followed by targeted therapies are transforming the way we tackle cancer treatment, leading to better clinical outcomes while reducing inefficiency in health care delivery.
Continuous Glucose Monitors and insulin pumps allow diabetics to avoid peaks and troughs in their blood sugar, substantially improving health care options.
Advances in sensor, data analytics and mobile technologies are widening the range of capabilities and extending the commercial possibilities of drones.
See how Portfolio Manager Andy Acker and Research Analyst Dan Lyons analyze biotechnology companies on the forefront of cancer research.
Watch why our technology Portfolio Managers see events such as the launch of Overwatch League as vital to determine potential impacts of new initiatives on companies and industries.